BioSpace News Archive

Under the terms of the deal, Amgen is buying all outstanding shares of Rodeo with a $55 million upfront payment. In addition, there are potential milestone payments that could hit $666 million in cash.

Citing Russia’s agricultural regulatory agency, Reuters reported the new vaccine called Carnivac-Cov will be used against the virus in dogs, cats, foxes and mink.

Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has provided the initial financing for the initiation of formal drug development and preclinical planning; based upon proprietary nanoemulsion technology licensed from NanoSmart Pharmaceuticals.

I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologic, announced its participation in the following conferences in April.

Positive safety profile in NORSE THREE open-label safety study reinforces previously reported safety data for ONS-5010 / LYTENAVA™ , an investigational ophthalmic formulation of bevacizumab-vikg for the treatment of wet AMD Topline efficacy and safety data from pivotal Phase 3 NORSE TWO study on target to report in calendar Q3 2021,

Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2020. These results are included in the Company’s Annual Report on Form 10-K, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov .

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce topline data from the Phase 2b part of its Phase 2b/3 COVID-19 trial of NP-120 (Ifenprodil).

CVS Health announced new goals in support of its long-term corporate social responsibility strategy, Transform Health 2030, and released its 14th annual CSR report.

Frontier Medicines, Corp., a precision medicine company drugging challenging protein targets to develop breakthrough medicines that change the course of human diseases, today announced the appointment of Gregory Chow as chief financial officer.

Each year the National Kidney Foundation highlights the work of one of thousands of kidney health professionals for their community service and educational activities in promoting NKF’s mission on a local level and presents that person with the Medical Advisory Board Distinguished Service Award.